AKT2, a member of the AKT kinase family, is frequently upregulated in various cancers, including CRC [27], where it contributes to the EMT process via the phosphatidylinositol 3′ kinase (PI3K)/AKT pathway [28]. This evidence concerns the gene AKT2 and colorectal carcinoma.